Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000242 · ClinicalTrials.gov registry record · Phase 2
Carbamazepine Treatment of Cocaine Dependence - 1
A Phase 2 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00000242: Completed Phase 2 study, sponsored by Medical University of South Carolina.
NCT00000242 is a Phase 2 study that has completed, run by Medical University of South Carolina. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000242, a Phase 2 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this study is to compare the efficacy of carbamazepine in treatment of cocaine-dependence in patients with affective disorders.
Interventions
- DRUG Carbamazepine
Trial Details
| Field | Value |
|---|---|
| Start Date | 1992-10-01 |
| Est. Completion | 1997-01-25 |
| Phase | Phase 2 |
What the finished NCT00000242 record still lists
NCT00000242 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Carbamazepine is the first listed.
NCT00000242 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000242 about?
NCT00000242 is a clinical study titled "Carbamazepine Treatment of Cocaine Dependence - 1". The purpose of this study is to compare the efficacy of carbamazepine in treatment of cocaine-dependence in patients with affective disorders.
What is the current status of trial NCT00000242?
This trial is currently completed. It is a Phase 2 study. The study started on 1992-10-01. Estimated completion is 1997-01-25.
What interventions are being tested in trial NCT00000242?
The interventions under investigation include: Carbamazepine (DRUG).
Who is sponsoring clinical trial NCT00000242?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI